Text and Data Mining valid from 2019-04-01
Received: 23 August 2018
Accepted: 1 March 2019
First Online: 3 April 2019
: C.R.B. is a co-founder and Scientific Advisory Board member of Palleon Pharmaceuticals, Enable Bioscience, InterVenn Bio and Redwood Bioscience (a subsidiary of Catalent), and a member of the Board of Directors of Eli Lilly and Company. T.W.-C., C.R.B., M.C.B., J.V.P., B.A.H.S. and M.S.H. are co-inventors on a patent application related to the work published in this paper.